Consistent with the notion that AHR-activating dioxins might be risk factors for the development of autoimmune disease [44], She et al. reported that DCs derived from PBC patients but not from healthy donors enhanced inflammatory Th1 and Th17 differentiation upon TCDD exposure [44]. This evidence concerns the gene AHR and autoimmune disease.